Out-of-Stock – COVID-19 – Authorisations for the temporary import and distribution of human medicines – Update

Link permanente della pagina
www.swissmedic.ch/out-of-stock-covid19-en

Status as of 01.06.2023

In Ordinance 3 on Measures to Combat the Coronavirus (Covid-19 Ordinance 3, SR 818.101.24), the Federal Council issues provisions designed to ensure the supply of important medical goods. Based on Art. 22 para. 3 of this ordinance, Swissmedic can approve the import of essentially identical medicinal products as a short-term solution for any temporary non-availability of medicinal products.

Medicinal products imported by hospital pharmacists under their own responsibility according to Art. 22 para. 1 of the Covid-19 Ordinance 3 are not included in this list.

The following table lists the temporary import and distribution licences granted by Swissmedic on the basis of the Covid-19 Ordinance. The goods are usually allocated and information provided on their respective availability by the department at the Federal Office of Public Health responsible for procuring medical goods.

Distribution period ongoing

Active substance Pharmaceutical form / Dosage Batch reference Distribution licensed until
Casirivimab / Imdevimab Concentrato per soluzione per infusione, 120mg/mL N7601B04 30.06.2023
Propofol Emulsion for injection/infusion, 10 mg/ml (in a pre-filled syringe)   RY659 30.06.2023

Distribution period elapsed: products may still be present at the dispensing outlets; dispensing and use permitted until the batches have expired

Active substance Pharmaceutical form / Dosage Batch reference Distribution licensed until
Propofol Emulsione iniettabile/infusione, 10 mg/ml, 50ml flaconi K20018B 31.12.2022
Remdesivir Powder for preparation of a solution for infusion, 100 mg C2000141D2
20410871D1
00009D
00009D4
00010D2
20411011M
AP0083BM1
AP0425BM1
25.11.2022
Remifentanil Powder for preparation of a solution for infusion, 5 mg D38B 31.12.2021
Lopinavir / Ritonavir Film-coated tablets, 200 mg/tab. and 50 mg/tab. 1125683
1125601
1126558
31.12.2020
Lopinavir / Ritonavir Syrup, 400 mg/5 ml and 100 mg/5 ml 6088549 31.12.2020
Midazolam Ampoules, 50 mg/10 ml F1058F02 31.12.2020